Switch to:

iCo Therapeutics EV-to-EBITDA

: -3.25 (As of Today)
View and export this data going back to 2009. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, iCo Therapeutics's enterprise value is $5.01 Mil. iCo Therapeutics's EBITDA for the trailing twelve months (TTM) ended in Jun. 2020 was $-1.54 Mil. Therefore, iCo Therapeutics's EV-to-EBITDA for today is -3.25.

OTCPK:ICOTF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -5.9   Med: -1.7   Max: 0.1
Current: -2.78

-5.9
0.1

During the past 13 years, the highest EV-to-EBITDA of iCo Therapeutics was 0.10. The lowest was -5.90. And the median was -1.70.

OTCPK:ICOTF's EV-to-EBITDA is ranked lower than
99.99% of the 280 Companies
in the Biotechnology industry.

( Industry Median: 31.71 vs. OTCPK:ICOTF: -2.78 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2020-11-24), iCo Therapeutics's stock price is $0.03. iCo Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2020 was $-0.03. Therefore, iCo Therapeutics's PE Ratio for today is .

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


iCo Therapeutics EV-to-EBITDA Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

iCo Therapeutics Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 -1.14 -1.55 -2.49 -5.85

iCo Therapeutics Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.38 -14.17 -5.85 -2.54 -3.52

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


iCo Therapeutics EV-to-EBITDA Distribution

* The bar in red indicates where iCo Therapeutics's EV-to-EBITDA falls into.



iCo Therapeutics EV-to-EBITDA Calculation

iCo Therapeutics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=5.010/-1.542279699329
=-3.25

iCo Therapeutics's current Enterprise Value is $5.01 Mil.
iCo Therapeutics's EBITDA for the trailing twelve months (TTM) ended in Jun. 2020 was -0.39574050298316 (Sep. 2019 ) + -0.49510213379907 (Dec. 2019 ) + -0.46991404011461 (Mar. 2020 ) + -0.18152302243211 (Jun. 2020 ) = $-1.54 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


iCo Therapeutics  (OTCPK:ICOTF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

iCo Therapeutics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.03/-0.025122078734729
=

iCo Therapeutics's share price for today is $0.03.
iCo Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2020 was -0.0029861792915943 (Sep. 2019 ) + -0.0075935910091882 (Dec. 2019 ) + -0.007163323782235 (Mar. 2020 ) + -0.0073789846517119 (Jun. 2020 ) = $-0.03.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


iCo Therapeutics EV-to-EBITDA Related Terms


iCo Therapeutics EV-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)